Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05856136 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle

StatusRecruiting
PhasePhase 4
Started2023-06-19
View on ClinicalTrials.gov ↗

Amendment history

2026-06-18
Study Status v8
Completion pushed: 2026-06-01 → 2027-01-01
2026-02-24
Study Status, Outcome Measures v7
Primary endpoints1 entry, revised
Change in Young's modulus (derived from shear wave speed)
2026-02-13
Study Status v6
Primary completion dateestimated 2026-01-01→confirmed 2025-12-08
Completion date2026-04-01→2026-06-01
2025-10-21
Active, Not Recruiting→Recruiting Study Status, Study Design, Contacts/Locations v5
Trial statusActive, Not Recruiting→Recruiting
Primary completion date2024-10-31→2026-01-01
Completion date2025-12-31→2026-04-01
Study sitesdetails revised at 1 of 1 site
2025-07-01
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v4
Trial statusRecruiting→Active, Not Recruiting
Primary completion dateestimated 2025-06→confirmed 2024-10-31
Completion date2025-06→2025-12-31
Enrollment targetestimated 200→confirmed 69
Study sitesdetails revised at 1 of 1 site
Show 3 earlier versions
2024-07-10
Study Status, References v3
Primary completion date2024-04→2025-06
Completion date2024-04→2025-06
2023-08-15
Study Status v2
Primary completion date2023-12→2024-04
Completion date2023-12→2024-04
Start dateestimated 2023-06→confirmed 2023-06-19
2023-06-05
Study Status v1
Start date2023-05→2023-06
2023-05-04
Original filing
Mayo Clinic
1,015 trials monitored
See 115 trials at risk
The purpose of this study is to evaluate opioid dose effects on the ability of the diaphragm muscle to generate higher force behaviors.
Trial Details
NCT Number NCT05856136
Lead Sponsor Mayo Clinic
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Respiratory Function Loss, Respiratory Complication
Enrollment 69 participants
Start Date 2023-06-19
Primary Completion 2025-12-08 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-17